AMY DEPALMA: Open Payments
NPI 1659760221 · SUGARLOAF, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,196 in 152 payments from 16 companies in 2025. Trend: 2023 $2,893 · 2024 $3,137 · 2025 $3,196
Food & beverage: $3,099Education: $96
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 20 | $451 |
| Janssen Biotech, Inc. | 22 | $445 |
| Novartis Pharmaceuticals Corporation | 12 | $333 |
| UCB, Inc. | 18 | $330 |
| Amgen Inc. | 12 | $288 |
| Lilly USA, LLC | 12 | $284 |
| ABBVIE INC. | 15 | $272 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $236 |
| Regeneron Healthcare Solutions, Inc. | 9 | $196 |
| GENZYME CORPORATION | 4 | $99 |
Products named: NEMLUVIO, TREMFYA, Bimzelx, DUPIXENT, OTEZLA, COSENTYX, SKYRIZI, ILUMYA.
Industry payments across PA — which companies pay providers there.
